328 related articles for article (PubMed ID: 31023262)
1. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
Kaczmarski KR; Sozio SM; Chen J; Sang Y; Shafi T
BMC Nephrol; 2019 Apr; 20(1):138. PubMed ID: 31023262
[TBL] [Abstract][Full Text] [Related]
2. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.
Egan BM; Zhao Y; Axon RN; Brzezinski WA; Ferdinand KC
Circulation; 2011 Aug; 124(9):1046-58. PubMed ID: 21824920
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
[TBL] [Abstract][Full Text] [Related]
5. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
[TBL] [Abstract][Full Text] [Related]
7. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension.
Gu Q; Dillon CF; Burt VL; Gillum RF
Am J Hypertens; 2010 Jan; 23(1):38-45. PubMed ID: 19851295
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.
Petersen J; Malyutina S; Ryabikov A; Kontsevaya A; Kudryavtsev AV; Eggen AE; McKee M; Cook S; Hopstock LA; Schirmer H; Leon DA
BMC Cardiovasc Disord; 2020 Mar; 20(1):135. PubMed ID: 32169049
[TBL] [Abstract][Full Text] [Related]
10. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
[TBL] [Abstract][Full Text] [Related]
11. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.
Bundy JD; Mills KT; Chen J; Li C; Greenland P; He J
JAMA Cardiol; 2018 Jul; 3(7):572-581. PubMed ID: 29800138
[TBL] [Abstract][Full Text] [Related]
12. Apparent treatment resistant hypertension and the risk of recurrent cardiovascular events and mortality in patients with established vascular disease.
Groenland EH; Bots ML; Asselbergs FW; de Borst GJ; Kappelle LJ; Visseren FLJ; Spiering W;
Int J Cardiol; 2021 Jul; 334():135-141. PubMed ID: 33932429
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
[TBL] [Abstract][Full Text] [Related]
14. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
[TBL] [Abstract][Full Text] [Related]
17. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.
Sarfo FS; Ovbiagele B
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105401. PubMed ID: 33096498
[TBL] [Abstract][Full Text] [Related]
18. National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
Vemulapalli S; Deng L; Patel MR; Kilgore ML; Jones WS; Curtis LH; Irvin MR; Svetkey LP; Shimbo D; Calhoun DA; Muntner P
Am Heart J; 2017 Apr; 186():29-39. PubMed ID: 28454830
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
[TBL] [Abstract][Full Text] [Related]
20. Apparent Treatment-Resistant Hypertension in the First Year Associated With Cardiovascular Mortality in Peritoneal Dialysis Patients.
Zhu Q; Huo Z; Zeng F; Gong N; Ye P; Pan J; Kong Y; Dou X; Wang D; Huang S; Yang C; Liu D; Zhang G; Ai J
Am J Hypertens; 2024 Jun; 37(7):514-522. PubMed ID: 38252960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
